HealthDay

Rates of Osteonecrosis of the Jaw Low for Denosumab-Treated Women

THURSDAY, Feb. 14, 2019 (Pharmacist's Briefing) -- For denosumab-treated women with postmenopausal osteoporosis, invasive oral procedures and events (OPEs), including dental implants, tooth extraction, natural tooth loss, scaling/root planning, and jaw surgery, are common and associated with osteonecrosis of the jaw (ONJ), although the overall rate of ONJ is low, according to a study published online Feb. 13 in the Journal of Clinical Endocrinology & Metabolism

Read More

HealthDay

Risk for MRSA Reduced With Postdischarge Decolonization

THURSDAY, Feb. 14, 2019 (Pharmacist's Briefing) -- For patients colonized with methicillin-resistant Staphylococcus aureus (MRSA), postdischarge MRSA decolonization is associated with a reduced risk for infection, according to a study published in the Feb. 14 issue of the New England Journal of Medicine

Read More

HealthDay

What Your Patients Are Reading

Flu Shot Much More Effective This Year, CDC Says

THURSDAY, Feb. 14, 2019 (Pharmacist's Briefing) -- This year's flu shot is already outperforming the vaccine issued during the tough 2017-2018 influenza season, federal health officials reported Thursday

Read More

HealthDay

Hot Topics

CDC: Severity of Influenza Season Low Through Feb. 2, 2019

THURSDAY, Feb. 14, 2019 (Pharmacist's Briefing) -- The 2018 to 2019 influenza season has been low in severity so far, and overall vaccine effectiveness is about 47 percent, according to two reports published in the Feb. 15 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report

Read More

HealthDay

Industry News You Can Use

Medicare Patients With MS Face Higher Out-of-Pocket Rx Costs

THURSDAY, Feb. 14, 2019 (Pharmacist's Briefing) -- Medicare patients with multiple sclerosis (MS) face increasing out-of-pocket costs for disease-modifying therapies, according to a study published in the February issue of Health Affairs

Read More